Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Antiparkinson Agents (pharmacokinetics) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (metabolism) < Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology)  Facettes :

List of bibliographic references indexed by Antiparkinson Agents (pharmacokinetics)

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000333 (2016) Cicely Kerr [Royaume-Uni] ; Emily J. Lloyd [Royaume-Uni] ; Charlotte E. Kosmas [Royaume-Uni] ; Helen T. Smith [Royaume-Uni] ; James A. Cooper [Royaume-Uni] ; Karissa Johnston [Canada] ; Emma Mcintosh [Royaume-Uni] ; Andrew J. Lloyd [Royaume-Uni]Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.
000538 (2015) Emma D. Deeks [Oman]Safinamide: first global approval.
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001F94 (2009) Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada]Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients
002441 (2007) Vicki Oldfield [États-Unis] ; Gillian M. Keating ; Caroline M. PerryRasagiline: a review of its use in the management of Parkinson's disease.
002A01 (2005) Tom H. Johnston [Canada] ; Susan H. Fox ; Jonathan M. BrotchieAdvances in the delivery of treatments for Parkinson's disease.
002C55 (2004) Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
004469 (1992) S. Gauthier [Canada] ; D. AmyotSustained release antiparkinson agents: controlled release levodopa.
004985 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (pharmacokinetics)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacokinetics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacokinetics)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022